Approach to the Treatment of Children and Adolescents with Obesity.
Intensive health and behavior lifestyle modification
Metabolic and bariatric surgery
Obesity pharmacotherapy
Pediatric obesity
Journal
Gastrointestinal endoscopy clinics of North America
ISSN: 1558-1950
Titre abrégé: Gastrointest Endosc Clin N Am
Pays: United States
ID NLM: 9202792
Informations de publication
Date de publication:
Oct 2024
Oct 2024
Historique:
medline:
15
9
2024
pubmed:
15
9
2024
entrez:
14
9
2024
Statut:
ppublish
Résumé
Pediatric obesity continues to be an omnipresent disease; 1 in 5 children and adolescents have obesity in the United States. The comorbidities associated with youth-onset obesity tend to have a more severe disease progression in youth compared to their adult counterparts with the same obesity-related condition. A comorbidity of focus in this study is metabolism-associated steatotic liver disease (MASLD), which has rapidly evolved into the most common liver disease seen in the pediatric population. A direct association exists between the treatment of MASLD and the treatment of pediatric obesity. The current evidence supports that obesity treatment is safe and effective.
Identifiants
pubmed: 39277305
pii: S1052-5157(24)00057-6
doi: 10.1016/j.giec.2024.06.004
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
781-804Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have no financial relationships or conflict of interest relevant to this article to disclose. Conflict of interest: The authors have no financial relationships or conflict of interest relevant to this article to disclose.